Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Administration of antibody to the lung protects mice against pneumonic plague.

Literature DB >> 16622253

Administration of antibody to the lung protects mice against pneumonic plague.

Jim Hill¹, Jim E Eyles, Stephen J Elvin, Gareth D Healey, Roman A Lukaszewski, Richard W Titball.

Abstract

Intratracheal delivery of aerosolized monoclonal antibodies with specificity for Yersinia pestis LcrV and F1 antigens protected mice in a model of pneumonic plague. These data support the utility of inhaled antibodies as a fast-acting postexposure treatment for plague.

Entities: Disease Species

Mesh：

Substances：

Year: 2006 PMID： 16622253 PMCID： PMC1459704 DOI： 10.1128/IAI.74.5.3068-3070.2006

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

26 in total

Review 1. Emerging protein delivery methods.

Authors: J L Cleland; A Daugherty; R Mrsny
Journal: Curr Opin Biotechnol Date: 2001-04 Impact factor: 9.740

Review 2. Pulmonary delivery of drugs for bone disorders.

Authors: J S Patton
Journal: Adv Drug Deliv Rev Date: 2000-08-31 Impact factor: 15.470

Review 3. Yersinia pestis (plague) vaccines.

Authors: Richard W Titball; E Diane Williamson
Journal: Expert Opin Biol Ther Date: 2004-06 Impact factor: 4.388

4. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge.

Authors: G P Andrews; D G Heath; G W Anderson; S L Welkos; A M Friedlander
Journal: Infect Immun Date: 1996-06 Impact factor: 3.441

5. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague.

Authors: E D Williamson; S M Eley; A J Stagg; M Green; P Russell; R W Titball
Journal: Vaccine Date: 1997-07 Impact factor: 3.641

Review 6. Preventing infectious disease with passive immunization.

Authors: L Zeitlin; R A Cone; T R Moench; K J Whaley
Journal: Microbes Infect Date: 2000-05 Impact factor: 2.700

7. Non-invasive pulmonary aerosol delivery in mice by the endotracheal route.

Authors: Maytal Bivas-Benita; Raphaël Zwier; Hans E Junginger; Gerrit Borchard
Journal: Eur J Pharm Biopharm Date: 2005-07-20 Impact factor: 5.571

8. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague.

Authors: S E Leary; E D Williamson; K F Griffin; P Russell; S M Eley; R W Titball
Journal: Infect Immun Date: 1995-08 Impact factor: 3.441

Review 9. Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.

Authors: L Zeitlin; R A Cone; K J Whaley
Journal: Emerg Infect Dis Date: 1999 Jan-Feb Impact factor: 6.883

10. Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.

Authors: Colin W Shepard; Montse Soriano-Gabarro; Elizabeth R Zell; James Hayslett; Susan Lukacs; Susan Goldstein; Stephanie Factor; Joshua Jones; Renee Ridzon; Ian Williams; Nancy Rosenstein
Journal: Emerg Infect Dis Date: 2002-10 Impact factor: 6.883

23 in total

1. Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague.

Authors: Danielle A Wagner; Sean M Kelly; Andrew C Petersen; Nathan Peroutka-Bigus; Ross J Darling; Bryan H Bellaire; Michael J Wannemuehler; Balaji Narasimhan
Journal: Acta Biomater Date: 2019-10-11 Impact factor: 8.947

2. Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plague.

Authors: Devender Kumar; Girish Kirimanjeswara; Dennis W Metzger
Journal: Clin Vaccine Immunol Date: 2011-08-31

3. Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion.

Authors: Addie Embry; Xiangzhi Meng; Angelene Cantwell; Peter H Dube; Yan Xiang
Journal: Vaccine Date: 2011-06-12 Impact factor: 3.641

4. Affinity maturation of an anti-V antigen IgG expressed in situ through adenovirus gene delivery confers enhanced protection against Yersinia pestis challenge.

Authors: T J Van Blarcom; C Sofer-Podesta; J Ang; J L Boyer; R G Crystal; G Georgiou
Journal: Gene Ther Date: 2010-04-15 Impact factor: 5.250

5. Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.

Authors: Anthony J Hickey; Jr-Shiuan Lin; Lawrence W Kummer; Frank M Szaba; Debra K Duso; Michael Tighe; Michelle A Parent; Stephen T Smiley
Journal: Infect Immun Date: 2013-04-01 Impact factor: 3.441

Review 6. Antibodies for biodefense.

Authors: Jeffrey W Froude; Bradley Stiles; Thibaut Pelat; Philippe Thullier
Journal: MAbs Date: 2011-11-01 Impact factor: 5.857

7. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.

Authors: Frank M Szaba; Lawrence W Kummer; Lindsey B Wilhelm; Jr-Shiuan Lin; Michelle A Parent; Sara W Montminy-Paquette; Egil Lien; Lawrence L Johnson; Stephen T Smiley
Journal: Infect Immun Date: 2009-07-20 Impact factor: 3.441

8. Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.

Authors: Betty L Noel; Sarit Lilo; Daniel Capurso; Jim Hill; James B Bliska
Journal: Clin Vaccine Immunol Date: 2009-08-26

9. Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis.

Authors: Maya I Ivanov; Betty L Noel; Ryan Rampersaud; Patricio Mena; Jorge L Benach; James B Bliska
Journal: Infect Immun Date: 2008-09-02 Impact factor: 3.441

10. Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.

Authors: Philip A Arlen; Michael Singleton; Jeffrey J Adamovicz; Yi Ding; Abdolreza Davoodi-Semiromi; Henry Daniell
Journal: Infect Immun Date: 2008-05-27 Impact factor: 3.441